Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas

Pretargeted radioimmunotherapy (PRIT) using streptavidin (SA)–conjugated antibodies (Abs), followed by clearing agent and radiolabeled biotin is a promising method that can increase the effectiveness of RIT, while decreasing the toxicities associated with directly labeled Abs. Although CD20 has been...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Pantelias, Anastasia, Pagel, John M., Hedin, Nathan, Saganic, Laura, Wilbur, Shani, Hamlin, Donald K., Wilbur, D. Scott, Lin, Yukang, Stone, Diane, Axworthy, Don, Gopal, Ajay K., Press, Oliver W.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2007
נושאים:
Neoplasia
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885529/
https://ncbi.nlm.nih.gov/pubmed/17303693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-11-056895
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים